CLOV CLOVER HEALTH INV CORP

Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage

Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage

Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience

WILMINGTON, Del., April 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced the appointment of Dr. Shelly Gupta as Chief Medical Officer (“CMO”). Dr. Gupta will oversee Clover’s innovative clinical operations, quality initiatives, pharmacy operations, and precision-based chronic disease management programs, directly focusing on patient choice, provider autonomy, and delivering transparent, value-driven healthcare.

Dr. Gupta brings extensive healthcare experience to Clover as a trained family practice physician with over a decade of experience in Medicare Advantage leadership and a proven record of enhancing clinical outcomes for senior populations. Prior to joining Clover Health, Dr. Gupta held various CMO leadership roles at Humana where he successfully led regional MA plans and the launch of the Humana Healthy Horizons Medicaid plan. His achievements include measurable reductions in hospitalizations and emergency visits, enhancing care coordination across healthcare settings, and playing an integral role in improving health outcomes for members with chronic disease complications. Dr. Gupta’s extensive background has enabled him to drive impactful results, and his experience in improving quality and patient access will be vital in advancing Clover Health’s Medicare Advantage operations.

“I’m thrilled to join Clover Health, which stands apart in Medicare Advantage through its commitment to physician independence and its innovative use of clinical data to empower personalized care decisions with Clover Assistant,” said Dr. Gupta. “Now more than ever, it’s critical to reduce bureaucratic barriers and enhance patient-provider relationships. Clover’s dedication to utilizing innovative Clover Assistant technology to enhance care delivery perfectly aligns with these goals, and deeply resonates with my own values. I look forward to working with the team to continually demonstrate how open networks and precise clinical insights directly benefit seniors, physicians, and the overall healthcare system.”

In his new role at Clover Health, Dr. Gupta will focus on leveraging advanced data-driven solutions and innovative technology to optimize Clover’s Medicare Advantage clinical operations. He will work closely with physicians, health systems, and internal teams to improve care delivery, increase member satisfaction, and further the Company’s value-based care initiatives. Dr. Gupta will also be instrumental in advancing Clover’s patient-access initiatives and fostering collaboration with healthcare providers to ensure all Medicare beneficiaries have access to the care they need.

“Dr. Gupta’s exceptional expertise in operationalizing clinical innovation makes him an ideal addition to the Clover Health leadership team,” said Jamie Reynoso, CEO of Medicare Advantage, Clover Health. “His alignment with our core mission – using cutting-edge technology to simplify healthcare decisions and empower providers – is precisely what differentiates Clover in the market. Dr. Gupta’s passion for improving health outcomes and commitment to innovation will be key to Clover Health’s vision of a healthier future for seniors nationwide.”

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on , as well as the earlier identification and management of and .

Investor Relations:

Ryan Schmidt

Press Inquiries:



EN
07/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health Reports Second Quarter 2025 Results; Delivering Strong S...

Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-yearSecond quarter 2025 Total revenues of $478 million, up 34% year-over-yearSecond quarter 2025 profitability metrics with GAAP Net loss of $11 million, Adjusted EBITDA of $17 million, and Adjusted Net income of $17 million Updates Full Year 2025 Guidance: Increases Average Medicare Advantage membership to 104,000 - 108,000, representing 32% growth year-over-year at the midpointMaintains Insurance revenue between $1.800...

 PRESS RELEASE

Primary Care Physician Use of Counterpart Assistant Technology Linked ...

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in hospitalizations (15% lower) and 30-day readmissions (18% lower). WILMINGTON, Del., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary o...

 PRESS RELEASE

Clover Health Applauds White House and CMS’ Push to “Tear Down Digital...

Clover Health Applauds White House and CMS’ Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians Clover Health’s AI platform, Counterpart Assistant, already connects to a majority of the data networks named in yesterday’s pledge – eliminating the “digital walls,” delivering proven outcomes in chronic disease care, and supporting independent doctors caring for seniors in rural and other underserved areas WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), ...

 PRESS RELEASE

Counterpart Health Appoints Vicky Bruner as Vice President of Operatio...

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today announced the appointment of Vicky Bruner as Vice President of Operations. As Counterpart scales to meet growing demand from payors and providers nationwide, Bruner will lead several critical functio...

 PRESS RELEASE

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual...

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 11:00 a.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch